NovoCure

NVCR Small Cap

Healthcare · Medical Devices

Aktualisiert: Apr 5, 2026, 17:43 UTC

$10.55

-2.68% heute

52W: $9.82 – $20.06

52W Low: $9.82 Position: 7.1% 52W High: $20.06

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

—

Erwartetes KGV

P/S Ratio

1.83x

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$1.2B

Marktkapitalisierung

Umsatzwachstum

8.1%

YoY Umsatzwachstum

Gewinnmarge

-20.79%

Nettomarge

ROE

-38.89%

Eigenkapitalrendite

Beta

0.82

Marktsensitivität

Short Interest

11.71%

% der Aktien leerverkauft

Ø Volumen

1,912,900

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Kaufen

7 Analysten

Ø Kursziel

$26.07

+147.12% Upside

Kursziel Spanne

$13.50 – $49.00

Über das Unternehmen

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Sektor: Healthcare Branche: Medical Devices Land: Switzerland Mitarbeiter: 1,605 Börse: NMS

Trading-Daten

50-Day MA: $12.06

200-Day MA: $13.07

Volumen: 1,103,587

Ø Volumen: 1,912,900

Short Ratio: 3.86

Kurs/Buchwert: 3.49x

Verschuldung/EK: 72.94x

Free Cash Flow: $-37,975,376

Wo kann ich NovoCure kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →